| Followers | 513 |
| Posts | 80822 |
| Boards Moderated | 13 |
| Alias Born | 10/14/2009 |
Monday, October 14, 2013 5:36:36 PM
Update to the Allen Licht lawsuit against AJENE WATSON, JAMES GIBBS, ERIC L. NOVESHEN, YISROEL A. BORNSTEIN, ARYEH GOLDSTEIN, SAMUEL H. EISENBERG, THERESA LEE FREY, JEFFREY E. STALLER, CURT KRAMER, DAVID E. PRICE, TOMER TAL, STEVEN KOIFMAN, SCOTT H. WILDING, MONICA CHUI-TIRU, AJENE WATSON LLC, ENVISION CAPITAL LLC, SCB & ASSOCIATES LLC, THE TRIPOD GROUP LLC, VIRMMAC LLC,HERITAGE CORPORATE SERVICES INC, ASHER ENTERPRISES INC, STOCK STREET CAPITAL LLC, and SKYLINE CAPITAL INVESTMENTS INC
More information about the Allen Licht lawsuit found here:
http://www.scribd.com/doc/112739347/Watson
Relevant tickers include: EDWY, SMEV, UCHB, OTHM
A default judgement will be entered against David E. Price because David E. Price failed to respond to the lawsuit.
http://www.scribd.com/doc/128760969/David-E-Price-Default-Judgement
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85324550
More information about the Allen Licht lawsuit found here:
http://www.scribd.com/doc/112739347/Watson
Relevant tickers include: EDWY, SMEV, UCHB, OTHM
A default judgement will be entered against David E. Price because David E. Price failed to respond to the lawsuit.
http://www.scribd.com/doc/128760969/David-E-Price-Default-Judgement
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85324550
Recent RMTG News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 03:05:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/14/2026 09:20:25 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 03:48:57 PM
- RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind • ACCESS Newswire • 03/26/2026 11:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:12:56 PM
- RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit • ACCESS Newswire • 11/18/2025 12:59:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:59:17 PM
- RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership • ACCESS Newswire • 10/21/2025 11:59:00 AM
- RMTG Expands into Brazil with Strategic Representation Agreement • ACCESS Newswire • 10/14/2025 11:59:00 AM
- RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries • ACCESS Newswire • 10/08/2025 11:59:00 AM
- RMTG Partners with BKFC as Official Regenerative Medicine Provider • ACCESS Newswire • 09/29/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:32:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2025 08:06:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/30/2025 04:15:10 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/12/2025 01:56:55 AM

